Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis-Reference-Cited by-同舟云学术

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

Published:2009-06 Issue:6 Volume:145 Page:733-740
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Else Monica,Dearden Claire E.,Matutes Estella,Garcia-Talavera Juan,Rohatiner Ama Z. S.,Johnson Steve A. N.,O’Connor Nigel T. J.,Haynes Andy,Osuji Nnenna,Forconi Francesco,Lauria Francesco,Catovsky Daniel

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07668.x/fullpdf

Reference26 articles.

1. Consensus resolution: proposed criteria for evaluation of response to treatment in hairy cell leukemia;Anonymous;Leukemia,1987

2. Leukemic reticuloendotheliosis;Bouroncle;Blood,1958

3. Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712);Byrd;Blood,2003

4. Hairy cell leukaemia and prolymphocytic leukaemia;Catovsky;Clinics in Haematology,1977

5. Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up;Cervetti;British Journal of Haematology,2008

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemia;eJHaem;2024-08-30

2. Real‐world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL‐CLLEAR study;Hematological Oncology;2024-05

3. Direct Synthesis of α- and β-2′-Deoxynucleosides with Stereodirecting Phosphine Oxide via Remote Participation;Journal of the American Chemical Society;2024-03-14

4. Новая коронавирусная инфекция COVID-19 у пациентов с волосатоклеточным лейкозом;Clinical Oncohematology;2024-02-20

5. Therapy with mosunetuzumab, a bispecific antibody for relapsed/refractory hairy cell leukemia;Leukemia & Lymphoma;2024-01-22